Erratum: Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial (Lancet (2014) 384 (403-13))

M. Manns, P. Marcellin, F. Poordad

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalThe Lancet
Volume387
Issue number10030
DOIs
StatePublished - Apr 30 2016

ASJC Scopus subject areas

  • Medicine(all)

Cite this